There are some situations where you'll wish you had one.
Mac Studio 2026: Apple’s Biggest Desktop Leap Yet Is Coming Your email has been sent Originally launched in 2022, the compact powerhouse has been updated twice, but what’s coming next could be its ...
Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...
Discover 11 reasons your Mac storage is full and learn what takes up storage on Mac, plus simple tips to free up Mac disk space safely. Pixabay, markusspiske When Mac storage is full, everything slows ...
Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
After a somewhat tame 2025 that was largely marked by processor upgrades, 2026 is poised to be a huge year for the Mac, possibly the biggest since Apple unveiled the very first Macintosh in 1984. It ...
Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Electric vehicle fires ...
The concerns associated with electric vehicle battery fires are an oft-used talking point against the developing tech. Granted, there is some validity attached to those fears, as EV fires are much ...
"Lots of people won't like that of me, but there'll be lots of my fans that would find that super interesting," he said of the posthumous project Ed Sheeran is thinking out loud — and long-term — with ...